Gastroretentive Drug Delivery Systems Market Size Worth $19.7 Billion By 2028: Grand View Research, Inc.
The global gastroretentive drug delivery systems market size is estimated
to reach USD 19.7 billion by 2028, registering a CAGR of 6.4%, according to a new report by Grand View Research, Inc. Gastroretentive Drug Delivery Systems (DDSs) offer possible advantages for the drug with poor bioavailability, as their absorption is restricted to the upper Gastrointestinal Tract (GIT) and can be delivered proficiently. Hence enhancing absolute bioavailability and maximizing its absorption is expected to boost market growth during the forecast period.
Key suggestions from the report:
The floating drug delivery systems held the largest market share in 2020
His online talk is available on the website of the Norwich Society, which he is a member of.
Mr Hooton said between 1870s and 1890s there were an estimated 600 pubs within the historic city walls, compared to around 80 that now exist.
He said there were a variety of reasons why there were fewer pubs running now, from changing habits in society including buying supermarket alcohol and households watching more television in the evenings, to taxation and stricter drink drive laws.
There was also a reduction in pubs around the 19th century because of the temperance movement, which saw a rise against the consumption of alcoholic drinks in society.
His online talk is available on the website of the Norwich Society, which he is a member of.
Mr Hooton said between 1870s and 1890s there were an estimated 600 pubs within the historic city walls, compared to around 80 that now exist.
He said there were a variety of reasons why there were fewer pubs running now, from changing habits in society including buying supermarket alcohol and households watching more television in the evenings, to taxation and stricter drink drive laws.
There was also a reduction in pubs around the 19th century because of the temperance movement, which saw a rise against the consumption of alcoholic drinks in society.
Virginia health officials said Friday that the Food Drug and Administration could authorize the emergency use of Pfizer s vaccine for children as young as 12 sometime in mid-to-late May.